These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

284 related items for PubMed ID: 12734353

  • 1. TNF enhances CD4+ T cell alloproliferation, IFN-gamma responses, and intestinal graft-versus-host disease by IL-12-independent mechanisms.
    Brown GR, Lee EL, Thiele DL.
    J Immunol; 2003 May 15; 170(10):5082-8. PubMed ID: 12734353
    [Abstract] [Full Text] [Related]

  • 2. TNF-TNFR2 interactions are critical for the development of intestinal graft-versus-host disease in MHC class II-disparate (C57BL/6J-->C57BL/6J x bm12)F1 mice.
    Brown GR, Lee E, Thiele DL.
    J Immunol; 2002 Mar 15; 168(6):3065-71. PubMed ID: 11884480
    [Abstract] [Full Text] [Related]

  • 3. IL-12-independent LIGHT signaling enhances MHC class II disparate CD4+ T cell alloproliferation, IFN-gamma responses, and intestinal graft-versus-host disease.
    Brown GR, Lee EL, El-Hayek J, Kintner K, Luck C.
    J Immunol; 2005 Apr 15; 174(8):4688-95. PubMed ID: 15814693
    [Abstract] [Full Text] [Related]

  • 4. Enhancement of MHC class I-stimulated alloresponses by TNF/TNF receptor (TNFR)1 interactions and of MHC class II-stimulated alloresponses by TNF/TNFR2 interactions.
    Brown GR, Thiele DL.
    Eur J Immunol; 2000 Oct 15; 30(10):2900-7. PubMed ID: 11069072
    [Abstract] [Full Text] [Related]

  • 5. The role of TNF in hepatic histopathological manifestations and hepatic CD8+ T cell alloresponses in murine MHC class I disparate GVHD.
    El-Hayek JM, Rogers TE, Brown GR.
    J Leukoc Biol; 2005 Oct 15; 78(4):1001-7. PubMed ID: 16081594
    [Abstract] [Full Text] [Related]

  • 6. Tumor necrosis factor is critical for cytolytic T cell activity against allospecific hepatocytes and splenic targets in major histocompatibility complex class I disparate graft versus host disease.
    Ali S, Starwalt R, Kreck J, Whittington B, Brown GR.
    J Interferon Cytokine Res; 2011 May 15; 31(5):423-31. PubMed ID: 21091241
    [Abstract] [Full Text] [Related]

  • 7. T-cell activation and differentiation are regulated by TNF during murine DBA/2-->B6D2F1 intestinal graft-versus-host disease.
    Brown GR, Thiele DL.
    J Clin Immunol; 2000 Sep 15; 20(5):379-88. PubMed ID: 11051280
    [Abstract] [Full Text] [Related]

  • 8. CC chemokine receptor 2 expression in donor cells serves an essential role in graft-versus-host-disease.
    Rao AR, Quinones MP, Garavito E, Kalkonde Y, Jimenez F, Gibbons C, Perez J, Melby P, Kuziel W, Reddick RL, Ahuja SK, Ahuja SS.
    J Immunol; 2003 Nov 01; 171(9):4875-85. PubMed ID: 14568968
    [Abstract] [Full Text] [Related]

  • 9. Polarized type 2 alloreactive CD4+ and CD8+ donor T cells fail to induce experimental acute graft-versus-host disease.
    Krenger W, Snyder KM, Byon JC, Falzarano G, Ferrara JL.
    J Immunol; 1995 Jul 15; 155(2):585-93. PubMed ID: 7608537
    [Abstract] [Full Text] [Related]

  • 10. Fas-deficient lpr mice are more susceptible to graft-versus-host disease.
    van Den Brink MR, Moore E, Horndasch KJ, Crawford JM, Hoffman J, Murphy GF, Burakoff SJ.
    J Immunol; 2000 Jan 01; 164(1):469-80. PubMed ID: 10605044
    [Abstract] [Full Text] [Related]

  • 11. The p55 TNF-alpha receptor plays a critical role in T cell alloreactivity.
    Hill GR, Teshima T, Rebel VI, Krijanovski OI, Cooke KR, Brinson YS, Ferrara JL.
    J Immunol; 2000 Jan 15; 164(2):656-63. PubMed ID: 10623807
    [Abstract] [Full Text] [Related]

  • 12. Interleukin-12 preserves the graft-versus-leukemia effect of allogeneic CD8 T cells while inhibiting CD4-dependent graft-versus-host disease in mice.
    Yang YG, Sergio JJ, Pearson DA, Szot GL, Shimizu A, Sykes M.
    Blood; 1997 Dec 01; 90(11):4651-60. PubMed ID: 9373279
    [Abstract] [Full Text] [Related]

  • 13. Suppression of allograft responses induced by interleukin-6, which selectively modulates interferon-gamma but not interleukin-2 production.
    Tomura M, Nakatani I, Murachi M, Tai XG, Toyo-oka K, Fujiwara H.
    Transplantation; 1997 Sep 15; 64(5):757-63. PubMed ID: 9311716
    [Abstract] [Full Text] [Related]

  • 14. Host T cells resist graft-versus-host disease mediated by donor leukocyte infusions.
    Blazar BR, Lees CJ, Martin PJ, Noelle RJ, Kwon B, Murphy W, Taylor PA.
    J Immunol; 2000 Nov 01; 165(9):4901-9. PubMed ID: 11046015
    [Abstract] [Full Text] [Related]

  • 15. T cell subsets involved in lethal graft-versus-host disease directed to immunodominant minor histocompatibility antigens.
    Berger M, Wettstein PJ, Korngold R.
    Transplantation; 1994 Apr 15; 57(7):1095-102. PubMed ID: 7909395
    [Abstract] [Full Text] [Related]

  • 16. CP-690550, a Janus kinase inhibitor, suppresses CD4+ T-cell-mediated acute graft-versus-host disease by inhibiting the interferon-γ pathway.
    Park HB, Oh K, Garmaa N, Seo MW, Byoun OJ, Lee HY, Lee DS.
    Transplantation; 2010 Oct 27; 90(8):825-35. PubMed ID: 20697326
    [Abstract] [Full Text] [Related]

  • 17. Increased entry into the IFN-gamma effector pathway by CD4+ T cells selected by I-Ag7 on a nonobese diabetic versus C57BL/6 genetic background.
    Koarada S, Wu Y, Ridgway WM.
    J Immunol; 2001 Aug 01; 167(3):1693-702. PubMed ID: 11466393
    [Abstract] [Full Text] [Related]

  • 18. Osteopontin attenuates acute gastrointestinal graft-versus-host disease by preventing apoptosis of intestinal epithelial cells.
    Kawakami K, Minami N, Matsuura M, Iida T, Toyonaga T, Nagaishi K, Arimura Y, Fujimiya M, Uede T, Nakase H.
    Biochem Biophys Res Commun; 2017 Apr 01; 485(2):468-475. PubMed ID: 28192120
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Inhibition of Th1 polarization by soluble TNF receptor is dependent on antigen-presenting cell-derived IL-12.
    Becher B, Blain M, Giacomini PS, Antel JP.
    J Immunol; 1999 Jan 15; 162(2):684-8. PubMed ID: 9916686
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.